|
1
|
Rivera C: Essentials of oral cancer. Int J
Clin Exp Pathol. 8:11884–11894. 2015.PubMed/NCBI
|
|
2
|
Gupta PC: Mouth cancer in India: A new
epidemic? J Indian Med Assoc. 97:370–373. 1999.PubMed/NCBI
|
|
3
|
Mehrotra R, Singh M, Kumar D, Pandey A,
Gupta R and Sinha U: Age specific incidence rate and pathological
spectrum of oral cancer in Allahabad. Indian J Med Sci. 57:400–404.
2003.PubMed/NCBI
|
|
4
|
Zheng CM, Ge MH, Zhang SS, Tan Z, Wang P,
Zheng RS, Chen WQ and Xia QM: Oral cavity cancer incidence and
mortality in China, 2010. J Cancer Res Ther. 11 Suppl 2:C149–C154.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lingen MW, Kalmar JR, Karrison T and
Speight PM: Critical evaluation of diagnostic aids for the
detection of oral cancer. Oral Oncol. 44:10–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ries L, Eisner M, Kosary C, et al: Cancer
statistics review, 1975–2002. Bethesda, MD: National Cancer
Institute 21; 2005
|
|
7
|
Little CD, Nau MM, Carney DN, Gazdar AF
and Minna JD: Amplification and expression of the c-myc oncogene in
human lung cancer cell lines. Nature. 306:194–196. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Engelman JA, Zejnullahu K, Mitsudomi T,
Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen
J, et al: MET amplification leads to gefitinib resistance in lung
cancer by activating ERBB3 signaling. Science. 316:1039–1043. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dubik D, Dembinski TC and Shiu RP:
Stimulation of c-myc oncogene expression associated with
estrogen-induced proliferation of human breast cancer cells. Cancer
Res. 47:6517–6521. 1987.PubMed/NCBI
|
|
11
|
Chen CR, Kang Y and Massagué J: Defective
repression of c-myc in breast cancer cells: A loss at the core of
the transforming growth factor beta growth arrest program. Proc
Natl Acad Sci USA. 98:992–999. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Escot C, Theillet C, Lidereau R, Spyratos
F, Champeme MH, Gest J and Callahan R: Genetic alteration of the
c-myc protooncogene (MYC) in human primary breast carcinomas. Proc
Natl Acad Sci USA. 83:4834–4838. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng SY, Lai PL and Hsu HC: Amplification
of the c-myc gene in human hepatocellular carcinoma: Biologic
significance. J Formos Med Assoc. 92:866–870. 1993.PubMed/NCBI
|
|
14
|
Hsu T, Möröy T, Etiemble J, Louise A,
Trépo C, Tiollais P and Buendia MA: Activation of c-myc by
woodchuck hepatitis virus insertion in hepatocellular carcinoma.
Cell. 55:627–635. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pai R, Pai S, Lalitha R, Kumaraswamy S,
Lalitha N, Johnston R and Bhargava M: Over-expression of c-Myc
oncoprotein in oral squamous cell carcinoma in the South Indian
population. Ecancermedicalscience. 3:1282009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen YJ, Lin SC, Kao T, Chang CS, Hong PS,
Shieh TM and Chang KW: Genome-wide profiling of oral squamous cell
carcinoma. J Pathol. 204:326–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmittgen TD, Lee EJ, Jiang J, Sarkar A,
Yang L, Elton TS and Chen C: Real-time PCR quantification of
precursor and mature microRNA. Methods. 44:31–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu K, Li L, Rusidanmu A, Wang Y and Lv X:
Down-regulation of miR-1294 is related to dismal prognosis of
patients with esophageal squamous cell carcinoma through elevating
c-Myc expression. Cell Physiol Biochem. 36:100–110. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bustin SA: Quantification of mRNA using
real-time reverse transcription PCR (RT-PCR): TRends and problems.
J Mol Endocrinol. 29:23–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren X, Zhang Z, Tian J, Wang H, Song G,
Guo Q, Tian J, Han Y, Liao Q, Liu G, et al: The downregulation of
c-Myc and its target gene hTERT is associated with the
antiproliferative effects of baicalin on HL-60 cells. Oncol Lett.
14:6833–6840. 2017.PubMed/NCBI
|
|
22
|
Gerlier D and Thomasset N: Use of MTT
colorimetric assay to measure cell activation. J Immunol Methods.
94:57–63. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fotakis G and Timbrell JA: In vitro
cytotoxicity assays: Comparison of LDH, neutral red, MTT and
protein assay in hepatoma cell lines following exposure to cadmium
chloride. Toxicol Lett. 160:171–177. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Twentyman PR and Luscombe M: A study of
some variables in a tetrazolium dye (MTT) based assay for cell
growth and chemosensitivity. Br J Cancer. 56:279–285. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ferrari M, Fornasiero MC and Isetta AM:
MTT colorimetric assay for testing macrophage cytotoxic activity in
vitro. J Immunol Methods. 131:165–172. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Field J: Oncogenes and tumour-suppressor
genes in squamous cell carcinoma of the head and neck. Eur J Cancer
B Oral Oncol. 28:67–76. 1992. View Article : Google Scholar
|
|
28
|
Field JK, Spandidos DA, Stell PM, Vaughan
ED, Evan GI and Moore JP: Elevated expression of the c-myc
oncoprotein correlates with poor prognosis in head and neck
squamous cell carcinoma. Oncogene. 4:1463–1468. 1989.PubMed/NCBI
|
|
29
|
de Nigris F, Sica V, Herrmann J,
Condorelli G, Chade AR, Tajana G, Lerman A, Lerman LO and Napoli C:
c-Myc oncoprotein: cell cycle-related events and new therapeutic
challenges in cancer and cardiovascular diseases. Cell Cycle.
2:325–328. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takeda K, Kaisho T and Akira S: Toll-like
receptors. Annu Rev Immunol. 21:335–376. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moresco EM, LaVine D and Beutler B:
Toll-like receptors. Curr Biol. 21:R488–R493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Akira S, Takeda K and Kaisho T: Toll-like
receptors: Critical proteins linking innate and acquired immunity.
Nat Immunol. 2:675–680. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fig TLR: Toll-like receptors. 2017.
|
|
35
|
Aderem A and Ulevitch RJ: Toll-like
receptors in the induction of the innate immune response. Nature.
406:782–787. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: Update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takeda K and Akira S: Toll-like receptors
in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kawai T and Akira S: Toll-like receptors
and their crosstalk with other innate receptors in infection and
immunity. Immunity. 34:637–650. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mäkinen LK, Ahmed A, Hagström J, Lehtonen
S, Mäkitie AA, Salo T, Haglund C and Atula T: Toll-like receptors
2, 4, and 9 in primary, metastasized, and recurrent oral tongue
squamous cell carcinomas. J Oral Pathol Med. 45:338–345. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sutmuller RP, den Brok MH, Kramer M,
Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG
and Adema GJ: Toll-like receptor 2 controls expansion and function
of regulatory T cells. J Clin Invest. 116:485–494. 2006. View Article : Google Scholar : PubMed/NCBI
|
